Previous investigations in health subjects have reported a relationship between polyunsaturated long chain n-3 fatty acids and lower levels of pro-inflammatory biomarkers and the tumor marker CEA, supporting the concept that n-3 fatty acids may be useful in patients affected by diseases described by active inflammation. The gene discussed is CEACAM5; the disease is neoplasm.